🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This non-inferiority, randomized controlled trial aims to evaluate whether ...
Status
Terminated
Location
Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC
Start Date
2023-10-25
Trial ID
NCT04244981
Treatments Being Tested
To demonstrate that the efficacy of OCTAPLEX as a reversal agent in patient...
Status
Completed
Location
Octapharma Research Site
Start Date
2017-06-08
Trial ID
NCT02740335
Treatments Being Tested
The goal of this study will be to determine whether PCC confers any benefit...
Status
Withdrawn
Location
University of Utah Medical Center
Start Date
2015-04
Trial ID
NCT02429453
Treatments Being Tested
Apixaban is an anticoagulant (also known as blood thinner) approved by the ...
Status
Completed
Location
Thomas Jefferson University Hosptial
Start Date
2014-11
Trial ID
NCT02270918
The purpose of this study is to assess the independent effects of both a 4-...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-27
Trial ID
NCT02561923
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blind, placebo-contr...
Status
Terminated
Location
UAB Hospital
Start Date
2023-03-28
Trial ID
NCT05568888